The impact of the COVID-19 pandemic on healthcare-associated infections in intensive care unit patients: a retrospective cohort study

[1]  J. Timsit,et al.  COVID-19 increased the risk of ICU-acquired bloodstream infections: a case–cohort study from the multicentric OUTCOMEREA network , 2021, Intensive Care Medicine.

[2]  G. Dougan,et al.  Ventilator-associated pneumonia in critically ill patients with COVID-19 , 2021, Critical Care.

[3]  R. Bellomo,et al.  How I prescribe continuous renal replacement therapy , 2021, Critical Care.

[4]  Bryan C. Knepper,et al.  95. CAUTI and CLABSI in Hospitalized COVID-19 Patients , 2020 .

[5]  Daniel S Martin,et al.  Clinical characteristics and outcomes of critically ill patients with COVID-19 admitted to an intensive care unit in London: A prospective observational cohort study , 2020, PloS one.

[6]  G. Innes,et al.  Increase in Hospital-Acquired Carbapenem-Resistant Acinetobacter baumannii Infection and Colonization in an Acute Care Hospital During a Surge in COVID-19 Admissions — New Jersey, February–July 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[7]  L. Wee,et al.  Unintended consequences of infection prevention and control measures during COVID-19 pandemic , 2020, American Journal of Infection Control.

[8]  E. Casalino,et al.  Analysis of Emergency Department Visits and Hospital Activity during Influenza Season, COVID-19 Epidemic, and Lockdown Periods in View of Managing a Future Disaster Risk: A Multicenter Observational Study , 2020, International journal of environmental research and public health.

[9]  A. Lazzarin,et al.  Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors , 2020, Clinical Microbiology and Infection.

[10]  P. Póvoa,et al.  Clinical course and outcomes of critically ill patients with COVID-19 infection: a systematic review , 2020, Clinical Microbiology and Infection.

[11]  N. Schmit,et al.  Adapting hospital capacity to meet changing demands during the COVID-19 pandemic , 2020, BMC Medicine.

[12]  J. Cole,et al.  The impact of the COVID-19 pandemic on healthcare acquired infections with multidrug resistant organisms , 2020, American Journal of Infection Control.

[13]  A. Mellmann,et al.  A nosocomial cluster of vancomycin resistant enterococci among COVID-19 patients in an intensive care unit , 2020, Antimicrobial resistance and infection control.

[14]  M. Stevens,et al.  Antimicrobial stewardship programs and convalescent plasma for COVID-19: A new paradigm for preauthorization? , 2020, Infection Control & Hospital Epidemiology.

[15]  A. Michalsen,et al.  Decisions on the allocation of intensive care resources in the context of the COVID-19 pandemic , 2020, Medizinische Klinik - Intensivmedizin und Notfallmedizin.

[16]  T. Rebmann,et al.  Impact of SARS-CoV-2 on hospital acquired infection rates in the United States: Predictions and early results , 2020, American Journal of Infection Control.

[17]  M. Rupp,et al.  Fighting fear in healthcare workers during the COVID-19 pandemic , 2020, Infection Control & Hospital Epidemiology.

[18]  M. Cotter,et al.  Severe COVID-19 and healthcare-associated infections on the ICU: time to remember the basics? , 2020, Journal of Hospital Infection.

[19]  P. Pelosi,et al.  Bloodstream infections in critically ill patients with COVID‐19 , 2020, European journal of clinical investigation.

[20]  A. Chowdhary,et al.  The lurking scourge of multidrug resistant Candida auris in times of COVID-19 pandemic , 2020, Journal of Global Antimicrobial Resistance.

[21]  J. Laffey,et al.  Prone positioning in COVID-19 acute respiratory failure: just do it? , 2020, British Journal of Anaesthesia.

[22]  Larry Chu,et al.  Managing ICU surge during the COVID-19 crisis: rapid guidelines , 2020, Intensive Care Medicine.

[23]  M. Mckenney,et al.  The impact of the COVID-19 pandemic on emergency department visits and patient safety in the United States , 2020, The American Journal of Emergency Medicine.

[24]  P. Laterre,et al.  The challenge of ventilator-associated pneumonia diagnosis in COVID-19 patients , 2020, Critical Care.

[25]  N. Iorio,et al.  COVID-19: An Alert to Ventilator-Associated Bacterial Pneumonia , 2020, Infectious Diseases and Therapy.

[26]  H. Jacquier,et al.  Serratia marcescens outbreak in the intensive care unit during the COVID-19 pandemic: A paradoxical risk? , 2020, Médecine et Maladies Infectieuses.

[27]  Jie Dong,et al.  Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients , 2020, Cell Host & Microbe.

[28]  G. Cooke,et al.  Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  F. Petrini,et al.  Clinical ethics recommendations for the allocation of intensive care treatments in exceptional, resource-limited circumstances: the Italian perspective during the COVID-19 epidemic , 2020, Critical Care.

[30]  H. Thiele,et al.  Ventilation of COVID-19 patients in intensive care units , 2020, Herz.

[31]  G. Bearman,et al.  Impact of COVID-19 on traditional healthcare-associated infection prevention efforts , 2020, Infection Control & Hospital Epidemiology.

[32]  M. Netea,et al.  Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure , 2020, Cell Host & Microbe.

[33]  J. Laffey,et al.  Challenges and solutions for addressing critical shortage of supply chain for personal and protective equipment (PPE) arising from Coronavirus disease (COVID19) pandemic – Case study from the Republic of Ireland , 2020, Science of The Total Environment.

[34]  L. Riccioni,et al.  [Clinical ethics recommendations for the allocation of intensive care treatments, in exceptional, resource-limited circumstances.] , 2020, Recenti progressi in medicina.

[35]  G. Onder,et al.  Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. , 2020, JAMA.

[36]  D. Koh.  Occupational risks for COVID-19 infection , 2020, Occupational medicine.

[37]  Wenhong Zhang,et al.  Risks and features of secondary infections in severe and critical ill COVID-19 patients , 2020, Emerging microbes & infections.

[38]  D. Tufi,et al.  Multimodal surveillance of healthcare associated infections in an intensive care unit of a large teaching hospital. , 2019, Annali di igiene : medicina preventiva e di comunita.

[39]  D. Talbot,et al.  A descriptive review of variable selection methods in four epidemiologic journals: there is still room for improvement , 2019, European Journal of Epidemiology.

[40]  M. Ranieri,et al.  Effectiveness over time of a multimodal intervention to improve compliance with standard hygiene precautions in an intensive care unit of a large teaching hospital , 2019, Antimicrobial Resistance & Infection Control.

[41]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[42]  R. Evans.  European Centre for Disease Prevention and Control. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[43]  Sanjay Saint,et al.  Guidelines for the prevention of intravascular catheter-related infections. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[44]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[45]  Jason P. Fine,et al.  Statistical Primer for Cardiovascular Research Introduction to the Analysis of Survival Data in the Presence of Competing Risks , 2022 .